Vaccines are one of the most successful health interventions that bring about significant reductions in infectious diseases and adverse health consequences and improve quality of life in the population.
In a situation where there is abundance of new and expensive vaccines on one hand and limitations of resources on the other, it becomes imperative that use of vaccines through induction in the Universal Immunization Program (UIP) as well as in the free market is done through a framework of decision-making that confers positive health and economic benefits to the society. The UIP in India targets 2.7 Crores infants and 3.0 Crores pregnant women every year and is one of the largest in the world. The country also has a
strong vaccine manufacturing capacity that has recently taken on the challenge of producing more complex vaccines. Most of the new vaccines are used by one segment of the population, which can afford them, while the most vulnerable segment of the population, which is serviced through the UIP misses out on this opportunity.
Participate in a healthy discussion and debate about the UIP in India, vaccine policy in the US and Switzerland
Time: 10 am to 12 noon
Date: 22nd June 2013
Facilitated by Dr Dayaprasad G Kulkarni
No comments:
Post a Comment